When to refer
WHEN TO REFER
Pharmacy team members should refer to the pharmacist:
-
Any customer with symptoms that have lasted more than a few days -
Pregnant or breastfeeding women
-
Severe symptoms, or symptoms that are getting worse
-
Customers taking other medication
-
Babies or young children with congestion symptoms
1. https://cks.nice.org.uk/common-cold#!backgroundsub:4 (Accessed Nov 2018)
2. https://cks.nice.org.uk/influenza-seasonal#!backgroundsub:1 (Accessed Nov 2018)
3. https://www.nhs.uk/conditions/non-allergic-rhinitis/ (Accessed Nov 2018)
4. https://www.nhs.uk/conditions/sinusitis-sinus-infection (Accessed Nov 2018)
5. https://www.nhs.uk/conditions/decongestants (Accessed Nov 2018)
6. http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con052053.pdf (Accessed Nov 2018)
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to McNeil Products Limited on 01344 864 042.
Sudafed Congestion & Headache Relief Day & Night Capsules (paracetamol 500mg, caffeine 25mg, phenylephrine 6.1mg) Product Information
Presentation: Red/yellow day capsules containing paracetamol 500mg, caffeine 25mg, phenylephrine 6.1mg; dark blue/light blue night capsules containing paracetamol 500mg, phenylephrine 6.1mg. Uses: Symptomatic relief of common cold and influenza, including aches and pains, sore throat, headache, fatigue and drowsiness (day capsule only), nasal congestion and fever. Dosage: Adults and children over 16 years: 2 red/yellow caps every 4-6 hours during the day as required, followed by 2 dark blue/light blue caps at bedtime. Leave at least 4-6 hours between doses. Do not take more than 8 caps in 24 hours or continue for longer than 3 days without seeing a doctor. Not recommended for children under 16 years of age. Contraindications: Hypersensitivity to the active ingredients or excipients, severe coronary heart disease and cardiovascular disorders, hypertension, hyperthyroidism, patients currently receiving or within 2 weeks of stopping therapy with MAOIs. History of peptic ulcer (day capsules only). Concomitant use with other paracetamol containing products. Precautions: Severe renal or severe hepatic impairment, Raynaud's Phenomenon, diabetes mellitus. The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease. Keep out of the reach and sight of children. Possible interactions: metoclopramide, domperidone, colestyramine, anticoagulants, other sympathomimetics, vasodilators, beta-blockers, drugs which induce hepatic microsomal enzymes. See SPC for further details. Pregnancy and lactation: Consult doctor before use. Side effects: Nausea and insomnia (day capsules only). Adverse effects of paracetamol are rare but hypersensitivity including skin rash may occur. There have been reports of blood dyscrasias including thrombocytopenia and agranulocytosis, but these were not necessarily causally related to paracetamol. Very rare cases of serious skin reactions have been reported with paracetamol. Phenylephrine may elevate blood pressure with headache, vomiting and rarely palpitations; tachycardia or reflex bradycardia; tingling and coolness of the skin. Rare reports of allergic reactions. RRP (ex VAT): 16s (12 day/4 night): £4.16 Legal category: GSL PL holder: Wrafton Laboratories Ltd, Wrafton, North Devon, EX33 2DL PL Number: 12063/0073 Date of preparation: April 2017. UK/SU/15-5835(8)
Sudafed Congestion & Headache Relief Max Strength Capsules (paracetamol 500mg, caffeine 25mg, phenylephrine 6.1mg) Product Information
Presentation: Red/blue capsules containing paracetamol 500mg, caffeine 25mg, phenylephrine 6.1mg. Uses: Symptomatic relief of the pain and congestion of sinusitis, including relief of aches and pains, headache, nasal congestion and fever. Dosage: Adults and children over 16 years: 2 caps every 4-6 hours to a max of 4 doses in any 24 hours. Do not exceed 8 caps in any 24 hours. Dosage should not be continued for longer than 3 days without consulting a doctor. Contraindications: Use in children under 16 years, hypersensitivity, severe coronary heart disease and cardiovascular disorders, history of peptic ulcer, hypertension, hyperthyroidism, use with or within two weeks of receiving MAOIs. Precautions: Severe renal or severe hepatic impairment, Raynaud's Phenomenon, diabetes mellitus. The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease. Should not be taken concomitantly with other paracetamol containing medicines. Possible interactions: metoclopramide, domperidone, cholestyramine, monoamine oxidase inhibitors (including moclobemide), sympathomimetic amines, beta-blockers and other antihypertensives (including debrisoquine, guanethidine, reserpine, methyldopa), tricyclic antidepressants, digoxin and cardiac glycosides, ergot alkaloids, warfarin and other coumarins, vasodilators and drugs which induce hepatic microsomal enzymes. See SPC for further details. Pregnancy and lactation: Consult doctor before use. Side effects: Thrombocytopenia, agranulocytosis, anaphylaxis, cutaneous hypersensitivity reactions including skin rashes, angiodema and Stevens-Johnson syndrome, cross-sensitivity with other sympathomimetics, toxic epidermal necrolysis, bronchospasm and hepatic dysfunction, nervousness, anxiety, irritability, restlessness, excitability, dizziness, headache, insomnia, increased blood pressure, nausea, vomiting, diarrhoea, mydriasis, acute angle closure glaucoma, most likely to occur in those with closed angle glaucoma, tachycardia, palpitations, allergic reactions (e.g. rash, urticaria, allergic dermatitis), dysuria, urinary retention. See SPC for details. RRP (ex-VAT): 16s: £3.90 Legal category: GSL PL holder: Wrafton Laboratories Ltd, Wrafton, North Devon, EX33 2DL PL Number: 12063/0067 Date of preparation: March 2017. UK/SU/15-5940(7)
Sudafed Decongestant Tablets (pseudoephedrine HCl 60mg) Product Information
Presentation: Reddish-brown, round, biconvex film-coated tablets, with 'Sudafed' on one side. Tablets contain pseudoephedrine HCl 60mg. Uses: Symptomatic relief of allergic rhinitis, vasomotor rhinitis, common cold and influenza. Dosage: Adults and children over 12 years: 1 tablet every 4-6 hours up to 4 times a day. Contraindications: Hypersensitivity to ingredients, severe hypertension or coronary artery disease, with or within 2 weeks of receiving MAOIs. Precautions: Mild to moderate hypertension, renal impairment, severe hepatic impairment, heart disease, diabetes, hyperthyroidism, elevated intraocular pressure, prostatic enlargement. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Concomitant use of tricyclic antidepressants, bretylium, betanidine, guanethidine, debrisoquine, methyldopa, alpha and beta blockers, other sympathomimetic agents. Pregnancy and lactation: Not recommended. Side effects: Sleep disturbance, skin rash, urinary retention, rarely hallucinations. RRP (ex VAT): 12s, £3.47. Legal category: P PL Holder: McNeil Products Ltd., Foundation Park, Roxborough Way, Maidenhead, SL6 3UG PL Number: PL 15513/0024 Date of preparation: January 2013. UK/SU/15-5849(4)
Sudafed Blocked Nose Spray (xylometazoline hydrochloride 0.1% w/v) Product Information
Presentation: Metered dose bottle containing 0.1% w/v xylometazoline hydrochloride as an aqueous solution. Uses: Symptomatic relief of nasal congestion associated with colds, influenza, sinusitis, and rhinitis and other upper respiratory tract allergies. Dosage: Adults and children 12 years and over: 1 spray into each nostril 2-3 times daily up to a maximum of 3 sprays daily. Children under 12 years: Not recommended. Contraindications: Hypersensitivity to ingredients, with or within 2 weeks of receiving MAOIs, hypophysectomy or surgery exposing dura mater. Precautions: Coronary artery disease, hypertension, diabetes mellitus, hyperthyroidism. Prolonged treatment may lead to reactive hyperemia of the nasal mucosa. Pregnancy and lactation: Not recommended Side effects: Not Known: burning sensation mucosal, nasal discomfort, nasal dryness, nasal pruritus, rhinalgia, sneezing, rebound congestion. Rare: nausea and headache. RRP (ex VAT): £3.95 Legal category: GSL. PL Holder: McNeil Products Ltd., Foundation Park, Roxborough Way, Maidenhead, SL6 3UG. PL Number: PL 15513/0074. Date of preparation: 09 May 2018. UK/SU/17-8601(2)
Sudafed Blocked Nose Capsules (Phenylephrine hydrochloride 12mg) Product Information
Presentation: A yellow cap and body printed 'Sudafed 0593' in black. Uses: Relief of nasal congestion associated with colds and hayfever. Dosage: Adults and children over 12 years: one capsule up to 4 times a day. Under 12 years: not suitable. Contraindications: Hypersensitivity to ingredients, cardiovascular disease, diabetes, closed angle glaucoma, hyperthyroidism, prostatic enlargement, phaeochromocytoma, with or within 2 weeks of receiving MAOIs. Precautions: Occlusive vascular disease including Raynaud's phenomenon. Concurrent use of tricyclic antidepressants, other sympathomimetic drugs, vasodilators, beta blockers or enzyme inducers e.g. alcohol. Pregnancy and lactation: Not recommended. Side effects: Tachycardia, cardiac arrhythmias, palpitations, hypertension, nausea, vomiting, headache and occasionally urinary retention in males. RRP (ex VAT): 12s, £2.67; 24s, £4.78 Legal category: GSL PL Holder: McNeil Products Ltd., Foundation Park, Roxborough Way, Maidenhead, SL6 3UG PL Number: PL 15513/0125 Date of preparation: March 2014. UK/SU/15-5941(2)
Sudafed Sinus Pain Relief 200mg/6.1mg Tablets (ibuprofen 200mg, phenylephrine hydrochloride 6.1mg) Product Information
Presentation: Green, round bi-convex sugar-coated tablet. Uses: For the relief of symptoms of cold and flu with associated congestion, including aches and pains, headache, fever, sore throat, blocked nose and sinuses. Dosage: Adults, the elderly and children between 12 and 18 years: Two tablets every 8 hours, with or after food. Leave at least 4 hours between doses and do not exceed six tablets in any 24 hour period. A doctor should be consulted if the symptoms worsen or if the product is required for longer than 3 days in children between 12 and 18 years, or after 10 days in adults. Contraindications: Hypersensitivity to ibuprofen, aspirin, and other NSAIDS, phenylephrine hydrochloride or any of the excipients in the product. Hypertension and severe coronary heart disease. Active or history of recurrent peptic ulcer/haemorrhage. History of NSAID related gastrointestinal bleeding or perforation. Severe heart failure, renal failure or hepatic failure. Use with concomitant NSAIDs including cyclo-oxygenase-2 specific inhibitors. Patients being treated with monoamine oxidase inhibitors or within 14 days of ceasing such treatment. Patients with diabetes mellitus. Patients with closed angle glaucoma. Patients with hyperthyroidism. Patients suffering from prostatic enlargement. Patients suffering with phaeochromocytoma. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency. Precautions: Use with caution in the elderly, women trying conceive, dehydrated children, history of GI disease or toxicity, concomitant medications increasing the risk of GI toxicity, hepatic or renal dysfunction, bronchial asthma or allergic disease,; hypertension or heart failure, patients with increased risk factors for cardiovascular events, patients with occlusive vascular disease, SLE and mixed connective tissue disease. Should be used with caution in combination with: anti-coagulants, antihypertensives and diuretics, corticosteroids, anti-platelet agents and selective serotonin-reuptake inhibitors (SSRIs), cardiac glycosides, lithium, methotrexate, ciclosporin, mifepristone, tacrolimus, zidovudine, quinolone antibiotics, sympathomimetic amines, beta-blockers and other vasodilators, anticholinergic drugs, cardiac glycosides. Pregnancy and lactation: Not recommended. Side effects: Uncommon: hypersensitivity reactions with urticaria and pruritus, headache, tachycardia, cardiac arrhythmias, palpitations, hypertension, abdominal pain, nausea, dyspepsia, dizziness, tinnitus. Rare: diarrhoea, flatulence, constipation, vomiting, non-specific allergic reactions. Very rare: Urinary retention in males, acute renal failure, papillary necrosis, severe forms of skin reactions such as bullous reactions including Stevens-Johnson syndrome, erythema multiforme and toxic epidermal necrolysis can occur, liver disorders, peptic ulcer, perforation or gastrointestinal haemorrhage, melaena, haematemesis, ulcerative stomatitis, gastritis, exacerbation of ulcerative colitis and Crohn's disease, aseptic meningitis (singles cases), severe hypersensitivity reactions (anaphylaxis, angioedema or severe shock), haematopoietic disorders (anaemia, leucopenia, thrombocytopenia, pancytopenia, agranulocytosis). Not known: Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome). RRP (ex VAT): £4.58 Legal category: GSL. PL Holder: Galpharm Healthcare Limited, Wrafton, Braunton, Devon, EX33 2DL PL Number: PL 16028/0149 Date of preparation: 23 May 2018. UK/SU/17-9806(3)
Sudafed Sinus Pressure & Pain 200mg/30mg film-coated tablets (pseudoephedrine HCL 30mg and ibuprofen 200mg) Product Information
Presentation: Yellow, round film-coated tablets containing pseudoephedrine HCL 30mg and ibuprofen 200mg. Uses: Symptomatic treatment of nasal congestion associated with acute rhinosinusitis suspected to be of viral origin with headache and/or fever. Dosage: Adults and children over 15 years: 1 or 2 tablets every 6 hours, maximum 6 tablets per 24 hours. Under 15 years: Contraindicated. Contraindications: Hypersensitivity to ingredients, pregnant women during the third trimester of pregnancy, breast-feeding mothers, previous hypersensitivity reactions in response to acetylsalicylic acid or other NSAIDs, history of NSAID related gastrointestinal bleeding or perforation, history of recurrent peptic ulcer/haemorrhage, cerebrovascular or other bleeding, haematopoietic abnormalities, severe hepatic insufficiency, severe renal failure, severe heart failure (NYHA Class IV), severe cardiovascular disorders, tachycardia, hyperthyroidism, diabetes, pheochromocytoma, coronary heart disease, history of stroke, closed angle glaucoma, risk of urinary retention, history of seizures, history of myocardial infarction, systemic lupus erythematosus, concomitant use of other vasoconstrictor agents, concomitant use of MAOIs or their use within the last two weeks of receiving MAOIs, concomitant use with NSAIDs and other COX2 inhibitors, combination with medicines that can lower the epileptic threshold, not to be taken in cases of asthma unless advised by a doctor. Precautions: Severe skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur. Psychosis, concomitant administration of antimigraine agents, systemic lupus erythematosus and mixed connective tissue disease, patients with urethroprostatic disorders, blood clotting disorder, risk of gastro-intestinal bleeding, ulceration or perforation, history of gastrointestinal toxicity, caution with oral corticosteroids, anticoagulants, SSRIs or antiplatelet agents, heart failure, patients with chronically impaired renal or hepatic function, patients taking diuretics, patients who are hypovolaemic and the elderly, history of asthma, chronic headache, irritable bowel disease. Patients should consult a doctor if symptoms worsen. The maximum duration of treatment is 4 days for adults and 3 days for adolescents aged 15 years and older. Recommended dose and/or duration of treatment should not be exceeded. Increased doses may produce toxicity. Continuous use can lead to tolerance resulting in an increased risk of overdosing. Depression may follow rapid withdrawal. Overdosage may result in nausea and vomiting. Pregnancy and lactation: Contraindicated during the third trimester. Given only if necessary and under supervision of physician during first and second trimester. Side effects: Common: Gastrointestinal discomfort, dyspepsia, abdominal pain, nausea, vomiting, flatulence, diarrhoea, constipation, minor gastrointestinal blood loss in rare cases leading to anaemia, insomnia, dry mouth, nausea. Uncommon: Hypersensitivity reactions with urticaria, pruritus and asthma attacks (with drop in blood pressure), central nervous disturbances such as headache, dizziness, sleeplessness, agitation, irritability or tiredness, visual disturbances, gastrointestinal ulcers sometimes with bleeding and/or perforation, gastritis, ulcerative stomatitis, exacerbation of colitis and Crohn's disease, various skin rashes. Rare: Restlessness, tremor, hallucinations, tinnitus, exacerbation of asthma or hypersensitivity reaction with bronchospasm, kidney-tissue damage and elevated uric acid concentrations in the blood. Very rare: Exacerbation of infectious inflammations, aseptic meningitis (stiffness of the neck, headache, nausea, vomiting, fever or disorientation, mixed connective tissue disease), haematopoietic disorders, severe generalised hypersensitivity reactions, psychotic reactions, depression, palpitations, heart failure, myocardial infarction, arterial hypertension, oesophagitis, pancreatitis, intestinal diaphragm-like stricture, hepatic dysfunction, hepatic damage, particularly in long term therapy, hepatic failure, acute hepatitis, bullous reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis, alopecia, severe skin infections and soft-tissue complications in a varicella infection, Increase in serum creatinine, oedemas, nephrotic syndrome, interstitial nephritis, acute renal insufficiency, rash, pruritus. Not known: Agitation, hallucination, anxiety, abnormal behaviour, haemorhagic stroke, ischemic stroke, convulsion, headache, palpitations, tachycardia, chest pain, arrhythmia, hypertension, thirst, vomiting, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), urticaria, severe skin reaction including acute generalized exanthematous pustulosis (AGEP), hyperhidrosis, difficulty in micturition, euphoric mood, nervousness, somnolence, angioedema, urinary retention, dysuria. RRP (ex VAT): 12s, £3.86; 24s, £5.95 Legal category: P PL Holder: McNeil Products Ltd., Foundation Park, Roxborough Way, Maidenhead, SL6 3UG PL Number: PL 15513/0396 Date of preparation: 12 September 2018. UK/SU/18-11747(1)
Sudafed Sinus Max Strength Capsules (Paracetamol 500mg, Caffeine 25mg, Phenylephrine 6.1mg) Product Information
Presentation: Red/blue capsules containing paracetamol 500mg, caffeine 25mg, phenylephrine 6.1mg. Uses: Symptomatic relief of the pain and congestion of sinusitis, including relief of aches and pains, headache, nasal congestion and fever. Dosage: Adults and children over 16 years: 2 caps every 4-6 hours to a max of 4 doses in any 24 hours. Do not exceed 8 caps in any 24 hours. Dosage should not be continued for longer than 3 days without consulting a doctor. Contraindications: Use in children under 16 years; hypersensitivity, severe coronary heart disease and cardiovascular disorders, history of peptic ulcer, hypertension, hyperthyroidism, use with or within two weeks of receiving MAOIs. Precautions: Severe renal or severe hepatic impairment, Raynaud's Phenomenon, diabetes mellitus. The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease. Should not be taken concomitantly with other paracetamol containing medicines. Possible interactions: metoclopramide, domperidone, cholestyramine, monoamine oxidase inhibitors (including moclobemide), sympathomimetic amines, beta-blockers and other antihypertensives (including debrisoquine, guanethidine, reserpine, methyldopa), tricyclic antidepressants, digoxin and cardiac glycosides, ergot alkaloids, warfarin and other coumarins, vasodilators and drugs which induce hepatic microsomal enzymes. See SPC for further details. Pregnancy and Lactation: Consult doctor before use. Side effects: Thrombocytopenia, agranulocytosis, anaphylaxis, cutaneous hypersensitivity reactions including skin rashes, angiodema and Stevens Johnson syndrome, crosssensitivity with other sympathomimetics, toxic epidermal necrolysis, bronchospasm and hepatic dysfunction, nervousness, anxiety, irritability, restlessness, excitability, dizziness, headache, insomnia, increased blood pressure, nausea, vomiting, diarrhoea, mydriasis, acute angle closure glaucoma, most likely to occur in those with closed angle glaucoma, tachycardia, palpitations, allergic reactions (e.g. rash, urticaria, allergic dermatitis), dysuria, urinary. See SPC for details. RRP (ex VAT): 16s, £3.90 Legal category: GSL PL Holder: Wrafton Laboratories Ltd, Wrafton, North Devon. EX33 2DL. PL Number: PL 12063/0067 Date of prep: March 2017. UK/SU/17-9012 (2)
Sudafed Sinus-Ease 0.1% Nasal Spray (xylometazoline hydrochloride 0.1% w/v) Product Information
Presentation: Metered dose bottle containing 0.1% w/v xylometazoline hydrochloride as an aqueous solution. Uses: Symptomatic relief of nasal congestion associated with colds, influenza, sinusitis, and rhinitis and other upper respiratory tract allergies. Dosage: Adults and children 12 years and over: 1 spray into each nostril 2-3 times daily up to a maximum of 3 sprays daily. Children under 12 years: Not recommended. Contraindications: Hypersensitivity to ingredients, with or within 2 weeks of receiving MAOIs, hypophysectomy or surgery exposing dura mater. Precautions: Coronary artery disease, hypertension, diabetes mellitus, hyperthyroidism. Prolonged treatment may lead to reactive hyperemia of the nasal mucosa. Pregnancy and lactation: Not recommended. Side effects: Not Known: burning sensation mucosal, nasal discomfort, nasal dryness, nasal pruritus, rhinalgia, sneezing, rebound congestion. Rare: nausea and headache. RRP (ex VAT): £3.95 Legal category: GSL PL Holder: McNeil Products Ltd., Foundation Park, Roxborough Way, Maidenhead, SL6 3UG PL Number: PL 15513/0074 Date of preparation: 09 May 2018. UK/SU/18-11575
Sudafed Mucus Relief Triple Action Cold & Flu Tablets (paracetamol, guaifenesin, phenylephrine hydrochloride) Product Information
Presentation: Tablets containing 250mg paracetamol, 100mg guaifenesin, 5mg phenylephrine hydrochloride. Uses: Symptomatic relief of cold and flu, including aches and pains, headache, blocked nose, sore throat, chills and chesty cough. Dosage: Adults and children 12 years and over: 2 tablets every 4 hours as required. Do not take more than 8 tablets in 24 hours. Children under 12 years: Not recommended. Contraindications: Hypersensitivity to any of the ingredients, hepatic or severe renal impairment, hypertension, hyperthyroidism, diabetes, heart disease, glaucoma, including closed angle glaucoma, urinary retention, phaeochromocytoma, patients receiving other sympathomimetic drugs, or those taking tricyclic antidepressants or beta-blocking drugs, and those patients who are taking or have taken, within the last two weeks, MAOIs. Precautions: Patients suffering from chronic cough or asthma, enlargement of the prostate gland, occlusive vascular disease and cardiovascular disease should consult a physician before taking the product. Patients should stop using the product and consult a healthcare professional if cough lasts for more than 5 days or comes back, or is accompanied by a fever, rash or persistent headache. Not to be taken with a cough suppressant. Caution in patients with circulatory disorders, and prostatic hypertrophy. Use may give rise to insomnia, nervousness, hyperpyrexia, tremor, and epileptiform convulsions. Long-term use not recommended. See SPC for further information. Pregnancy and Lactation: This product should not be used during pregnancy or breastfeeding without medical advice. Side effects: Allergic reactions, angioedema, anaphylactic reactions, dyspnoea, nausea, vomiting, abdominal discomfort, diarrhoea, rash, urticaria, thrombocytopenia, agranulocytosis, bronchospasm, hepatic dysfunction, acute pancreatitis, nervousness, irritability, restlessness, excitability, headache, dizziness, insomnia, increased blood pressure, mydriasis, acute angle closure glaucoma, tachycardia, and palpitations. Price (ex-VAT): 16s: £4.16 Legal category: GSL PL holder: Wrafton Laboratories Ltd (T/A Perrigo), Braunton, Devon, EX33 2DL PL Number: 12063/0112 Date of preparation: 02 Mar 2016. UK/SU/15-5905(4)
Sudafed Mucus Relief Day & Night Capsules (paracetamol, phenylephrine, caffeine) Product Information
Presentation: Red/yellow day capsules containing paracetamol 500mg, caffeine 25mg, phenylephrine 6.1mg; dark blue/light blue night capsules containing paracetamol 500mg, phenylephrine 6.1mg. Uses: Symptomatic relief of common cold and influenza, including aches and pains, sore throat, headache, fatigue and drowsiness (day capsule only), nasal congestion and fever. Dosage: Adults and children over 16 years: 2 red/yellow caps every 4-6 hours during the day as required, followed by 2 dark blue/light blue caps at bedtime. Leave at least 4-6 hours between doses. Do not take more than 8 caps in 24 hours or continue for longer than 3 days without seeing a doctor. Not recommended for children under 16 years of age. Contraindications: Hypersensitivity to the active ingredients or excipients, severe coronary heart disease and cardiovascular disorders, hypertension, hyperthyroidism, patients currently receiving or within 2 weeks of stopping therapy with MAOIs. History of peptic ulcer (day capsules only). Concomitant use with other paracetamol containing products. Precautions: Severe renal or severe hepatic impairment, Raynaud's Phenomenon, diabetes mellitus. The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease. Keep out of the reach and sight of children. Possible interactions: metoclopramide, domperidone, colestyramine, anticoagulants, other sympathomimetics, vasodilators, beta-blockers, drugs which induce hepatic microsomal enzymes. See SPC for further details. Pregnancy and lactation: Consult doctor before use. Side effects: Nausea and insomnia (day capsules only). Adverse effects of paracetamol are rare but hypersensitivity including skin rash may occur. There have been reports of blood dyscrasias including thrombocytopenia and agranulocytosis, but these were not necessarily causally related to paracetamol. Very rare cases of serious skin reactions have been reported with paracetamol. Phenylephrine may elevate blood pressure with headache, vomiting and rarely palpitations; tachycardia or reflex bradycardia; tingling and coolness of the skin. Rare reports of allergic reactions. RRP (ex-VAT): 16s (12 day/4 night): £4.16 Legal category: GSL PL Holder: Wrafton Laboratories Ltd, Wrafton, North Devon, EX33 2DL PL Number: 12063/0073 Date of preparation: 26 Jan 2018. UK/SU/15-6016(5)
Sudafed Mucus Relief 0.1% Nasal Spray (xylometazoline hydrochloride 0.1% w/v) Product Information
Presentation: Metered dose bottle containing 0.1% w/v xylometazoline hydrochloride as an aqueous solution. Uses: Symptomatic relief of nasal congestion associated with colds, influenza, sinusitis, and rhinitis and other upper respiratory tract allergies. Dosage: Adults and children 12 years and over: 1 spray into each nostril 2-3 times daily up to a maximum of 3 sprays daily. Children under 12 years: Not recommended. Contraindications: Hypersensitivity to ingredients, with or within 2 weeks of receiving MAOIs, hypophysectomy or surgery exposing dura mater. Precautions: Coronary artery disease, hypertension, diabetes mellitus, hyperthyroidism. Prolonged treatment may lead to reactive hyperemia of the nasal mucosa. Pregnancy and Lactation: Not recommended. Side effects: Not known: burning sensation mucosal, nasal discomfort, nasal dryness, nasal pruritus, rhinalgia, sneezing, rebound congestion. Rare: nausea and headache. RRP (ex VAT): £3.95 Legal category: GSL PL Holder: McNeil Products Ltd., Foundation Park, Roxborough Way, Maidenhead, SL6 3UG PL Number: PL 15513/0074 Date of preparation: 09 May 2018. UK/SU/15-6145(6)